Who cares about the share price if they continue to pick up market share and can produce Narcotic Raw Material at 40% cheaper than their competitors. If all goes to plan, further increases in revenue should see strong profit growth in the next 2 years. Just hoping they don't get taken over by one of the big players.
The fact they have a Cannabis license seems pretty much irrelevant, but may be a distraction for some investors looking at the stock.